Effect of folic acid on myocardial perfusion sca
Phase 2
- Conditions
- Coronary artery disease (Atheroscelerosis).Atherosclerotic heart disease
- Registration Number
- IRCT2012120111624N1
- Lead Sponsor
- Vice chancellor for Research, Tehran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
Major
Type II diabetic patients;
Major exclusion criteria:
History of anti angina treatment or revascularization;
Evidence of Q wave in ECG referring to previous MI;
ECG based ST changes due to ischemia;
Active asthma;
Type II cardiac block or more;
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Myocardial perfusion. Timepoint: Before and two months after intervention. Method of measurement: MPI.
- Secondary Outcome Measures
Name Time Method TID. Timepoint: After MPI. Method of measurement: QPS software.;Hemocysteine blood level. Timepoint: Before MPI. Method of measurement: Blood level of hemocysteine.